Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
huCART19 in Pediatric and Young Adult B-ALL
NCT05480449Phase 2Recruiting
- Start
- Sep 2022
- Primary completion
- Sep 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of huCART-19 in B cell acute lymphoblastic leukemia (B-ALL), B-cell lymphoblastic lymphoma (B-LBL). Started Sep 2022; status: recruiting.
02
Drugs
huCART-19
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)B-cell lymphoblastic lymphoma (B-LBL)
Beyond the preview
Go deeper on NCT05480449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480449.